Urban, J. L. and Rothstein, J. L. and Shephard, M. H. and Schreiber, H. (1987) Tumor Necrosis Factor:A Potent Mediator of Macrophage-Dependent Tumor-Cell Killing. In: Modern Trends in Human Leukemia VII: New Results in Clinical and Biological Research Including Pediatric Oncolog. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion. No.31. Springer , Berlin, pp. 351-354. ISBN 978-3-540-17754-8. https://resolver.caltech.edu/CaltechAUTHORS:20200924-154443392
Full text is not posted in this repository. Consult Related URLs below.
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20200924-154443392
Abstract
Macrophages (Mφ) can be activated to show highly selective cytotoxicity toward malignant cells in vitro [6, 8, 9, 13, 14] and there is some evidence that they may destroy neoplastic cells in vivo [1]. The importance of activated Mφ (aMφ) in controlling tumor growth in vivo has been further implicated in experiments involving murine ultraviolet light (UV)-induced tumors, which are highly immunogenic regressor tumors [10] sensitive to Mφ in vitro [22]. Variants of these tumors demonstrating progressive growth in the normal host were found to invariably express an increased resistance to aMφ [22]. Furthermore, exposure of regressor tumor cells to aMφ in vitro also resulted in selection for Mφ-resistant cancer cells which displayed an increased early growth potential in vivo [22]. More recently we have utilized these tumor variants resistant to aMφ to explore the mechanism by which aMφ induce tumor cell destruction [23].
Item Type: | Book Section | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related URLs: |
| ||||||||||||
Additional Information: | © 1987 Springer-Verlag Berlin Heidelberg. This work was supported by grants CA-22677, CA-19266, CA-37156, 5-T32 AI-07090, and 5-T32 GMO-7281 from the National Institutes of Health. | ||||||||||||
Funders: |
| ||||||||||||
Subject Keywords: | Control Tumor Growth; Tumor Variant; Tumor Cytotoxicity; Frederick Cancer Research; Regressor Tumor | ||||||||||||
Series Name: | Haematology and Blood Transfusion / Hämatologie und Bluttransfusion | ||||||||||||
Issue or Number: | 31 | ||||||||||||
DOI: | 10.1007/978-3-642-72624-8_73 | ||||||||||||
Record Number: | CaltechAUTHORS:20200924-154443392 | ||||||||||||
Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20200924-154443392 | ||||||||||||
Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||||||||||
ID Code: | 105532 | ||||||||||||
Collection: | CaltechAUTHORS | ||||||||||||
Deposited By: | Tony Diaz | ||||||||||||
Deposited On: | 24 Sep 2020 23:04 | ||||||||||||
Last Modified: | 16 Nov 2021 18:43 |
Repository Staff Only: item control page